Heron Therapeutics (HRTX) Assets (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Assets came in at $246.2 million in Q1 2026, up 4.44% YoY from $235.8 million in Q1 2025, and down 3.78% on a QoQ basis from $255.9 million in Q4 2025.
Heron Therapeutics (HRTX) Assets (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Assets data on file, last reported at $246.2 million in Q1 2026.
- Quarterly Assets rose 4.44% year-over-year to $246.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.2 million (up 4.44% YoY) and the FY2025 annual result came in at $255.9 million, up 9.75% from the prior year.
- Assets eased to $246.2 million in Q1 2026, from $255.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $273.7 million in Q1 2022 to a low of $201.2 million in Q2 2023.
- A 5-year average of $236.7 million and a median of $233.1 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets plunged 39.65% — and 2025, when it gained 12.76%.
- Tracing HRTX's Assets over 5 years: stood at $251.0 million in 2022, then fell by 11.33% to $222.5 million in 2023, then increased by 4.78% to $233.1 million in 2024, then advanced by 9.75% to $255.9 million in 2025, then decreased by 3.78% to $246.2 million in 2026.
- The last three Assets figures came in at $246.2 million (Q1 2026), $255.9 million (Q4 2025), and $249.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Heron Therapeutics | 58.32 Mn | 15.65 Mn | 26.09 Mn | 252.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 252.26 Mn |
| Mar 31, 2026 | 246.22 Mn |
| Dec 31, 2025 | 255.88 Mn |
| Sep 30, 2025 | 248.95 Mn |
| Jun 30, 2025 | 232.09 Mn |
| Mar 31, 2025 | 235.75 Mn |
| Dec 31, 2024 | 233.15 Mn |
| Sep 30, 2024 | 220.78 Mn |
| Jun 30, 2024 | 218.14 Mn |
| Mar 31, 2024 | 217.89 Mn |
| Dec 31, 2023 | 222.51 Mn |
| Sep 30, 2023 | 229.20 Mn |
| Jun 30, 2023 | 201.22 Mn |
| Mar 31, 2023 | 220.88 Mn |
| Dec 31, 2022 | 250.95 Mn |
| Sep 30, 2022 | 271.95 Mn |
| Jun 30, 2022 | 243.97 Mn |
| Mar 31, 2022 | 273.72 Mn |
| Dec 31, 2021 | 305.71 Mn |
| Sep 30, 2021 | 352.39 Mn |